Comment from Frakes Kyle

Summary: Kyle Frakes, Founder of Moonlight Longevity, strongly supports maintaining access to compounded Semax for clinical use in treating cerebral ischemia, cognitive protection, and migraines. He argues that Semax has a substantial 30-year safety and efficacy record in Russia and Ukraine and addresses a significant unmet clinical need in the United States.